Eye 2019: One-year results of half-dose photodynamic therapy versus one-third-dose photodynamic therapy in chronic or recurrent
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients - Ophthalmology Retina
Half-dose PDT for chronic central serous chorioretinopathy. Summary of... | Download Scientific Diagram
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy | BMC Ophthalmology | Full Text
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy - Ophthalmology
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization | Scientific Reports
Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study | PLOS ONE
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half -Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3 - American Journal of Ophthalmology
Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy | Journal of Ocular Pharmacology and Therapeutics
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy - Ophthalmology
Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser - Rijssen - 2021 - Acta Ophthalmologica - Wiley Online Library
JCM | Free Full-Text | Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization | Scientific Reports
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients - Ophthalmology Retina
Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy | PLOS ONE
Crossover to Half-dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy patients (SPECS) - ScienceDirect
JCM | Free Full-Text | Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy | HTML
Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment. - Document - Gale Academic OneFile
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy | SpringerLink
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial | Trials | Full Text
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial - American Journal of Ophthalmology
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy - Ophthalmology
Half-dose photodynamic therapy for serous non-neovascular retinal pigm | OPTH
Five emerging treatments show mixed results
